Both Foxp3 + CD4 + regulatory T cells (T reg cells) and local immune responses in nonlymphoid tissues have long been recognized as important elements of a well-orchestrated immune system, but only recently have these two fields of study begun to intersect. There is growing evidence that T reg cells are present in various nonlymphoid tissues in health and disease, that they have a unique phenotype and that their functions go beyond the classical modulation of immune responses. Thus, tissue T reg cells might add yet another level to classification of the T reg cell compartment into functional and/or phenotypic subtypes. In this Review, we summarize recent findings in this new field, discussing knowns and unknowns about the origin, phenotype, function and memory of nonlymphoid tissue-resident T reg cells.
Regulatory T cells that express the Foxp3 transcription factor, termed T reg cells, are one of the immune system's main bastions against inappropriate or overexuberant responses. They control autoimmunity, allergic and inflammatory reactions, and responses to infectious agents and tumors. Over the past decade, many studies have addressed differentiation of the majority of T reg cells in the thymus, generation of a minority in the periphery, homeostasis of the T reg cell compartment, and cellular and molecular mechanisms of T reg cell-mediated immunosuppression 1 . For the most part, these explorations have taken the average T reg cell residing in the spleen or lymph nodes to be a typical example.
However, it eventually became impossible to ignore the considerable heterogeneity of the Foxp3 + CD4 + compartment, especially once transcriptome analysis had become a routine tool 2 . Initially, T reg cell subphenotypes were delineated based on expression of activation or memory markers; adhesion molecules, notably integrin CD103; or homing receptors. But a major advance was the discovery of T reg cell functional diversity matched to the type of response being reined in. A subtype of T reg cells was discovered that depends on the transcription factor IRF4 to control T helper 2 (T H 2) cells, which also critically rely on IRF4 (ref. 3) . In parallel, a discrete chemokine receptor CXCR3 + T reg cell subtype was found, dependent on the T-bet transcription factor, that is specialized in regulating the activities of T H 1 cells, which also require T-bet for their differentiation and functions 4 . T reg cells that optimally regulate interleukin 17 (IL-17)-dependent or IL-27-dependent responses may be yet different subtypes 5, 6 . The relevance of these various subtypes was serendipitously confirmed in a recent study showing an N-terminal insertional mutation of Foxp3 to dampen IL-17-driven and IL-4-driven arthritis in the 'K/BxN' mouse model but to exacerbate type 1 diabetes in nonobese diabetic (NOD) mice, a T H 1 cell-type disorder 7 . Another notable match between the cells that regulate and those that are regulated is found in germinal centers: follicular regulatory (T FR ) cells and follicular helper (T FH ) cells both depend on transcriptional repressors Blimp-1 and Bcl-6 for their differentiation and homeostasis and on chemokine receptor CXCR5 for their localization 8, 9 . The advantage of such a matching is probably that it provokes colocalization to and/or cosurvival in discrete locations. Arming regulatory and effector cells with the same capabilities could be dangerous, but safeguards are in place; for example, T H 1 cell-type T reg cells poorly upregulate IL-12 receptor subunit IL-12Rβ2 upon induction of the transcriptional regulator STAT1 by interferon-γ, meaning that the differentiation of these cells to T H 1 effector cells is aborted 10 .
In this Review we focus on studies that go one step further, highlighting the phenotype and functions-sometimes exquisitely adapted-of T reg cells residing in nonlymphoid tissues. We will survey the populations of tissue-resident T reg cells focusing on a few particularly interesting examples, consider their origin, discuss potential cellular targets and weigh the concept of T reg cell memory. Lastly, we will highlight some general principles and knowledge gaps to fill.
Tissue-resident T reg cells: the landscape
The presence of a distinct population of T reg cells has been documented in several nonlymphoid tissues of both mice and humans: skin, intestinal mucosa, lung, liver, adipose tissue, autoimmune target tissues, infected tissues, grafts, placenta, tumors, atherosclerotic plaques and injured muscle are just some examples (refs. 11-21 and D.B., C.B. and D.M., unpublished data). It is clear from this extensive list that T reg cells can localize in healthy tissues, in tissues with various types and grades of inflammation, and in immunoprivileged sites. In every case where the comparison has been made, tissue-resident T reg cells are distinguishable from classical lymphoid-organ T reg cells in phenotype and function. Although they display some features of activated and/or effector cells 22 , certain properties make each tissueresident T reg cell population unique, such as by the expression of specific transcription factors, chemokine receptors or effector molecules; or by a distinct T cell antigen receptor (TCR) repertoire, migration pattern, mechanism of action or targets.
Currently, one of the best-characterized examples of tissue-resident T reg cells is the population found in visceral adipose tissue (VAT) 12 . T reg cells are enriched in VAT of lean, aged male mice, constituting more than 50% of the CD4 + T cell compartment at that site, a notably higher fraction than the 5-15% routinely observed in lymphoid organs, including in aged individuals. Microarray-based profiling of gene expression, confirmed by flow cytometry analyses, revealed VAT T reg cells to have a unique phenotype. Although they are bona fide T reg cells, as shown by their recapitulation of most of the classical T reg signature and by their functionality in standard in vitro suppression assays, they differentially express a panoply of genes in comparison with lymphoid-organ T reg cells. The set of loci overexpressed in VAT T reg cells includes those encoding several chemokine receptors (for example, chemokine receptors CCR1, CCR2 and CCR9), immunomodulatory cytokines (such as IL-10) and the transcription factor PPAR-γ, all of which confer unique functional properties to VAT T reg cells 12, 23 . As flow cytometry studies showed that some of those markers are not expressed by 100% of the fat T reg cells 12, 23 , it is not clear how heterogeneous the population is and whether this has functional importance or more prosaically marks cells at different cell-cycle or differentiation stages. The TCR repertoire is another feature contributing to the distinct phenotype of VAT T reg cells: the TCR sequences they employ have little overlap with those used by lymphoid-organ T reg cells (ref. 12 and D. Kolodin and colleagues, personal communication). In addition, there is a notable population expansion of certain T reg clones in adipose tissue, suggesting that recognition of particular antigens may be important in the accumulation of T reg cells in abdominal fat (see below).
The major driver of VAT T reg cell accumulation, phenotype and function is PPAR-γ (ref. 23) . A member of the nuclear receptor superfamily characterized as the 'master regulator' of adipocyte differentiation and function 24 , PPAR-γ interacts with Foxp3 to promote upregulation of the VAT T reg cell signature in in vitro transduction experiments. Mice lacking PPAR-γ only in T reg cells show a substantial and specific reduction in the frequency and number of T reg cells in VAT compared with their wild-type littermates, without any changes in lymphoid-organ T reg cell populations. Moreover, the few VAT T reg cells remaining in those PPAR-γ-deficient mice exhibit an underrepresentation of the VAT T reg signature. The fact that PPAR-γ expression in VAT T reg cells is much higher than that in any other T reg cell population, together with the observation that these cells can take up lipids by expressing CD36, the scavenger receptor 23 , suggests that tissue-resident T reg cells are attuned to local cues, which they can exploit for phenotypic and functional specialization as well as for preferential survival in the tissue microenvironment (Fig. 1) .
Another tissue-resident population of great interest are T reg cells that infiltrate injured and regenerating skeletal muscle (D.B., C.B. and D.M., unpublished data). Within days after skeletal muscle injury (of various types), T reg cells start to accumulate locally, with their frequency among CD4 + T cells increasing steadily to up to 50-60% and remaining at that frequency for weeks, long after local inflammation has resolved. Microarray-based gene-expression profiling revealed that muscle T reg cells have a unique transcriptome, more closely related to that of VAT T reg cells than to that of lymphoidorgan T reg cells. For example, genes encoding IL-10, the growth factor amphiregulin and the regulator of macrophage activation TIM-3 are highly expressed by T reg cells accumulated in muscle. Muscle T reg cells have a skewed TCR repertoire, which appears not to overlap with that of muscle conventional CD4 + T cells or of splenic T reg cells, and shows clear signs of clonal expansion. T reg cells also accumulate in skeletal muscle of dystrophic mice (such as mice carrying the mdx mutation in the dystrophin gene and dysferlin-deficient mice), whose chronic muscle injury has a genetic origin.
Given recent successes with immunomodulatory antitumor strategies (see Review by T.F. Gajewski et al. in this issue 25 ), there is a growing interest in the more heterogeneous group of tumor-infiltrating T reg cells. In solid tumors of nonlymphoid origin, T reg cells can account for 30-50% of CD4 + T cells, depending on the tumor type 19 . Like other tissue-resident T reg cells, those found in tumors have a distinctive phenotype that differentiates them from T reg cells found in the circulation or in lymphoid organs. Microarray-based profiling of gene expression in tumor-associated T reg cells is still lacking 26 , but Foxp3 + CD4 + T cells from several mouse and human tumors show increased expression of cell-surface markers such as CTLA-4, ICOS, TIM-3 and GITR as well as of suppressive cytokines such as IL-10 and TGF-β, and a variety of chemokine receptors 19, [27] [28] [29] [30] .
Who gets there, when and how? T reg cells are found in healthy tissues, although usually in very small numbers 11 . Upon challenges of different types (autoimmunity, infection or injury), T reg cell numbers, and often their frequencies, increase considerably. Diverse mechanisms, not mutually exclusive, have been proposed to explain the accumulation of T reg cells at different tissue sites: chemokine-based recruitment of circulating T reg cells, local TCR-driven or cytokine-driven expansion, conversion of local or circulating conventional CD4 + T cells, or prolonged survival (Fig. 1) . In some cases, for example, in tumor T reg cells, all of these mechanisms have been championed by one investigator or another 19, 26, 27, [31] [32] [33] [34] [35] .
As for other types of immune-system cells, recruitment of T reg cells to nonlymphoid tissues is governed by specific combinations of chemotactic molecules and their receptors (reviewed in ref. 36) . T reg cells residing in various tissues express distinct patterns of chemokine receptors and adhesion molecules in comparison with their lymphoidorgan counterparts, both at single-cell level and in terms of population npg frequencies 11, 23 . This finding is true even for T reg cells residing in noninflamed tissues such as skin, lung and liver, wherein an enrichment for CCR4 + CD103 (integrin α E ) + T reg cells is observed 11 . Ccr4 −/− T reg cells show impaired accumulation in healthy nonlymphoid tissues, and this dearth has functional consequences as mice defective in CCR4 + T reg cells develop severe skin inflammation and a less severe lung infiltrate. It seems that antigen-specific activation of T reg cells in subcutaneous lymph nodes under inflammatory conditions induces upregulation of CCR4, priming T reg cells to migrate to the affected tissue and to suppress immune responses locally. However, the origin of the small fraction of CCR4 + CD103 + T reg cells found in lymphoid tissues in the absence of antigen challenge remains unclear. In this regard, a study showed that, in humans, only few T reg cells express CCR4 at birth, but the majority expresses the gut-homing receptor α 4 β 7 , and the reverse pattern is true for adults 37 . The switch commences at 1.5-3 years of age and correlates with a change from a naive to memory T reg phenotype, which has been suggested to depend on the recognition of microbial antigens in the gut, although this point has yet to be definitively demonstrated. In addition to CCR4, an array of chemokine receptors can be involved, usually in a redundant fashion, in the recruitment of T reg cells to nonlymphoid tissues under various inflammatory conditions 38 . In some cases, the expression of a particular receptor by tissue-resident T reg cells is directly associated with the type of tissue, but in others it is related to the type of T cell response (T H 1, T H 2 or T H 17) occurring in the tissue and the accompanying T reg cell polarization, for example, the preferential recruitment of CCR6 + T reg cells and CXCR3 + T reg cells to sites with an ongoing T H 17 cell-or T H 1 cell-driven inflammation, respectively 4, 5 .
The pattern and timing of trafficking between lymphoid and nonlymphoid tissues is not well-defined in most cases. In a model of pancreatic islet transplantation, T reg cells first migrate from blood to the inflamed allograft, in a process dependent on CCR2, CCR4, CCR5, and P-and E-selectin ligands 39 . Upon activation in the allograft, they subsequently move to the draining lymph nodes in a CCR2-, CCR5-and CCR7-dependent fashion. This sequential migration is required for an efficient suppression of alloimmunity because impairment of either of the steps by abolishing expression of the relevant receptor(s) in T reg cells results in decreased graft survival.
Although not universally accepted, it has been suggested that the TCR repertoire of T reg cells is biased toward the recognition of self antigens 1 , which could facilitate the localization of T reg cells in nonlymphoid tissues to prevent harmful autoimmune attacks and collateral damage to the tissue resulting from inflammation or injury. Sequencing of the TCR repertoire of VAT T reg cells in either wild-type mice or a mouse line engineered to have only limited TCR diversity yielded several interesting observations (ref. 12; D. Kolodin and colleagues, personal communication). First, the sequences expressed by VAT T reg cells have little overlap with those expressed by conventional CD4 + T cells, either in adipose tissue or in lymphoid organs, arguing against T reg cell conversion in this context. Second, there are notable clonal expansions of T reg cells in VAT even in standard mice. Lastly, in the line with limited TCR diversity, it is possible to find examples, in the same or different individuals, of a repeated complementary-determining region 3 (CDR3) protein sequence specified by different nucleotide sequences. These findings argue that VAT T reg cells are responding to one or more local antigens, whether they be derived from lipids or proteins. By combining an ovalbumin-specific TCR transgenic model and the expression of ovalbumin in the skin, a recent study showed that engineered expression of a self antigen in a peripheral tissue can drive the activation and proliferation of TCR-transgenic T reg cells, which mediate resolution of organ-specific autoimmunity 40 . These antigen-specific T reg cells remain in the target tissue and are primed to attenuate subsequent autoimmune reactions when the antigen is re-expressed (see below), suggesting that antigen recognition is important for tissue T reg cell function and memory.
A recent report provided the first clear identification of antigen specificity of a natural population of tissue-resident T reg cells 41 . By sequencing the TCR repertoire of prostate tumor-infiltrating T reg cells, the authors identified a TCR αβ pair recurrently enriched in independent mice (named MJ23), whose sequences they used to generate a MJ23 TCR transgenic line. In tumor-free MJ23 TCR-transgenic mice, T reg cells are found selectively in the prostate and its draining lymph nodes, suggesting that the cloned TCR is specific for an antigen expressed in the normal prostate in addition to the malignant tissue. Selection of MJ23 TCR transgenic T reg cells is dependent on expression of Aire in the thymus, thereby linking two major mechanisms of immunological tolerance: one central, one peripheral. Although similar demonstrations for other tissue-resident T reg specificities will be necessary before one can definitively generalize, this work supports the hypothesis that tissue-resident T reg cells are generated in the thymus in response to self antigens and that this TCR specificity facilitates their localization and amplification in nonlymphoid tissues, especially in pathological situations such as inflammation or cancer in which an enhanced presentation of self antigen can occur in the periphery.
Although the majority of T reg cells differentiate in the thymus, a small fraction of them can be generated in the periphery, by conversion of Foxp3 − CD4 + T cells into Foxp3 + CD4 + T reg cells, termed 'peripheral T reg cells' (pT reg cells) to distinguish them from their thymic-derived counterparts. There has been a lot of interest in conversion as a mechanism of T reg cell accumulation in nonlymphoid tissues, although few studies have clearly demonstrated that, in certain sites and/or conditions, pT reg cells constitute a substantial proportion of tissue T reg cells. The intestinal lamina propria T reg pool is one of the main populations of nonlymphoid-tissue T reg cells impacted by conversion, and pT reg cells have been shown to contribute substantially to oral tolerance (reviewed in ref. 42 ). Exposure to agonist administered orally and specific microbial products strongly induce conversion in the lamina propria, which is reflected in the increased frequency of T reg cells as well as in the increased proportion of Helios − T reg cells in that tissue [43] [44] [45] [46] . The analysis of a mutant mouse bearing a deletion in the conserved noncoding sequence 1 (CNS1) enhancer region of the Foxp3 locus necessary for peripheral induction confirmed previous observations on lamina propria T reg cells and suggested that the accumulation and function of pT reg cells might be important at mucosal and feto-maternal interfaces, and perhaps little else 17, 47, 48 . Different populations of tolerogenic antigen-presenting cells promote Foxp3 induction at mucosal surfaces, such as CD103 + dendritic cells that produce retinoic acid in the intestinal lamina propria 43, 49 and tissue-resident macrophages in the lung mucosa 50 . A report showed that neurons can elicit conversion of encephalitogenic Foxp3 − CD4 + T cells into T reg cells in vitro, although evidence for in vivo conversion was weak 51 . The generation of pT reg cells has also been proposed to have a role in the accumulation of T reg cells in tumors 35, 52 , although the exact contribution of this mechanism versus recruitment and/or population expansion of thymically derived T reg cells remains controversial 26, 42 . In fact, a study using a mouse tumor model showed that both mechanisms can coexist and that the induction of tumoral pT reg cells is intrinsically influenced by the tumor microenvironment and the presence of a tumor-specific antigen 52 . 
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Lastly, the question remains as to how and when the few T reg cells found in healthy, unchallenged tissues are recruited to these sites. It is possible that a combination of specific expression of chemokine receptors and antigen specificity constantly brings a small number of T reg cells to the tissues throughout life. Alternatively, early seeding with T reg cells precursors during fetal life might occur, paralleling the phenomenon observed in tissue macrophages 53 , followed by self-renewal of the tissue-resident T reg cells. In theory, seeding during embryonic life could occur after or before thymic development, although extrathymic differentation of TCR αβ T cells remains controversial.
Immunological and nonimmunological targets
One of the major functions of T reg cells residing in nonlymphoid tissues is to control local inflammation. Since their initial discovery, Foxp3 + CD4 + cells were recognized to be potent suppressors of T cell responses, and this activity has been extended to tissue Foxp3 + cells. In addition, tissue T reg cells can strongly impact myeloid populations in the vicinity, inhibiting neutrophils and proinflammatory macrophages, and promoting the activities of anti-inflammatory macrophages and monocyte subsets (Fig. 2) .
As a particular example, VAT T reg cells may influence a broad spectrum of targets. Their elevated expression of factors such as IL-10 and CTLA-4, and their effectiveness in the typical in vitro suppression assay 12 suggest that VAT T reg cells can control conventional CD4 + T cell and CD8 + T cell populations in the adipose tissue, although in vivo experiments to substantiate this point are still lacking. They may also control co-resident myeloid cells, as suggested by an inverse correlation between the frequency of T reg cells and that of proinflammatory myeloid populations (CD11b + CD11c + F4/80 + macrophages and proinflammatory CD11b + Ly6C hi monocytes) observed in VAT depots 23, 54, 55 . Similarly, muscle T reg cells are important in controlling the proinflammatory to anti-inflammatory switch that occurs in the myeloid infiltrate of injured muscle; punctual ablation of T reg cells at the time of muscle injury results in prolonged accumulation of proinflammatory Ly6C hi monocytes in the injured tissue (D.B., C.B. and D.M., unpublished data).
Because of the ability of T reg cells to dampen immune responses that can eradicate malignancies, their accumulation in tumors is considered to be a tumor escape mechanism. Tumor-infiltrating T reg cells can be as effective as peripheral-blood T reg cells in T cellsuppression assays 31 or even considerably better 30 ; and, in many cases, a high frequency of intratumor T reg cells is correlated with poor prognosis 31, 56, 57 . T reg cells can also have anti-tumoral effects by inhibiting inflammation in the tumor environment. A strong link between inflammation and cancer exists in many tissues: inflammation can promote proliferation and survival of malignant cells, angiogenesis and metastasis 58, 59 . In line with these observations, in certain tumors, such as colorectal cancers, a high density of T reg cells correlates with a favorable prognosis 60, 61 . It has recently been proposed that T reg cell-mediated suppression of proinflammatory T H 17 cell responses to the dense microbiome of the large intestine is key to preventing tumor growth in the intestinal epithelium 61 .
There is growing evidence that T reg cells (in particular those residing in tissues) not only control T lymphocytes and other immunesystem cells but also regulate certain nonimmunological processes, including systemic metabolic indices 12, 23, 55, 62 , ischemic stroke 63, 64 , formation of atherosclerotic plaques 65, 66 , cardiac remodeling after myocardial infarction 67 , liver cholestasis and fibrosis 68 (Fig. 2) . In any case, these nontraditional roles can have profound impact on both homeostatic and pathophysiological processes and should be considered an important facet of T reg cell function.
An unusual property of VAT T reg cells is their control of metabolic indices, inhibiting local and systemic insulin resistance and glucose intolerance. VAT of obese individuals exhibits low-grade, chronic inflammation, which has been directly linked to the appearance of metabolic abnormalities, ultimately type 2 diabetes and the metabolic syndrome 69, 70 . That the frequency of VAT, but not of lymphoid-organ T reg cells, drops severely upon feeding mice with a high-fat diet (HFD) or in genetic models of obesity, first suggested that this T reg cell subset might influence local and/or systemic metabolism 12, 54 . Loss-offunction experiments, relying on punctual and specific T reg cell ablation in a transgenic mouse expressing the diphtheria toxin receptor under Foxp3 regulatory elements (Foxp3 DTR mutant mice), demonstrated increases in inflammatory mediators in the visceral fat depot, a decrease in insulin-stimulated insulin receptor tyrosine phosphorylation in VAT and the liver, and insulin resistance upon loss of T reg cells 12 . Conversely, gain-of-function experiments, which entailed treatment of HFD-fed mice with IL-2-anti-IL-2 complexes, resulted in enhanced expression of IL-10 in VAT, improved insulin sensitivity and improved glucose tolerance. These results were mirrored in a more recent experiments manipulating PPAR-γ expression or signaling: mice devoid of PPAR-γ only in T reg cells exhibited a strong reduction in VAT T reg cells and degradation of metabolic indices, whereas HFD-fed wild-type mice injected with a PPAR-γ agonist, pioglitazone, had a substantially more robust T reg cell population and metabolic improvements. The restoration of metabolic indices typically induced by treatment of HFD-fed mice with pioglitazone is only very partial in mice lacking PPAR-γ specifically in T reg cells 23 , demonstrating not only that the beneficial effects of this drug occur in part by targeting VAT T reg cells, but also that VAT (and not lymphoid) T reg cells are important in the control of the metabolic indices downstream npg of obesity and inflammation of the adipose tissue. At least part of this T reg cell influence may be directly on adipocytes, as one of their major mediators, IL-10, can engage receptors on adipocytes to downregulate proinflammatory cytokines and increase glucose uptake. T reg cells that accumulate in injured skeletal muscle also seem to impact nonimmunological processes, in this case tissue regeneration (D.B., C.B. and D.M., unpublished data). Mice punctually depleted of T reg cells exhibit impaired muscle repair according to multiple criteria, notably the functionality of satellite cells, key players in the regeneration of skeletal muscle. Muscle T reg cells overexpress amphiregulin, a growth factor that induces in vitro differentiation of satellite cells, which express amphiregulin receptors (D.B., C.B. and D.M., unpublished data), suggesting that local T reg cells could have a direct effect on skeletal muscle precursor cells.
The influence of T reg cells on the pathophysiology of ischemic stroke provides yet another example of nonimmune processes regulated by T reg cells. However, in this case, opposite effects have been reported by different investigators, so whether T reg cells are beneficial or detrimental to the outcome of ischemic stroke remains controversial. One study showed that T reg cells can be found in the postischemic brain, and that their depletion profoundly enhances brain damage and exacerbates the functional outcome 63 . Production of IL-10 by T reg cells may be their major mechanism of immunomodulation in the brain and of T reg cell-mediated cebroprotection. Unfortunately, these results conflict with another subsequently published study indicating that T reg cells promote acute ischemic stroke in mice by inducing dysfunction of the cerebral microvasculature 64 . Notably, this negative impact of T reg cells on recovery from stroke is unrelated to their classical immunoregulatory functions; in fact, the CD4 + T cell and macrophage populations infiltrating the ischemic tissue are not affected by the depletion of T reg cells. Rather, the negative influence seems to result from an interaction between T reg cells and activated cerebral endothelial cells and platelets. These contradictory findings on the role of T reg cells in stroke issue from different models of T reg depletion (anti-CD25-mediated depletion versus a Foxp3 DTR line), by the different stroke models used (permanent versus temporal; different ischemia times) or the timing of readout (late versus acute stages).
A liaison between T reg cells and endothelial cells has also been observed in the tumor microenvironment, in this case reflecting a proangiogenic effect by tumor-infiltrating Foxp3 + CD4 + cells 71 . Tumor hypoxia promotes the recruitment of T reg cells through induction of expression of the chemokine CCL28 in tumor cells. Elevated numbers of T reg cells expressing CCR10 accumulate in CCL28 + tumors, which exhibit increased growth and angiogenesis in comparison with CCL28 − tumors. Angiogenesis is dependent on the presence of tumorinfiltrating T reg cells, which not only enhance expression of vascular endothelial growth factor A (VEGFA) in tumor cells but also directly contribute to the tumor VEGFA pool by producing the proangiogenic factor themselves 71 . Tumor-infiltrating T reg cells also promote mammary carcinoma metastasis in the lung by the cytokine RANKL 72 . Thus, the impact of tumor-resident T reg cells on tumor growth and patient prognosis reflects both traditional (on immune targets) and nontraditional (on nonimmune targets) T reg cell functions. Dissection of the individual pathways regulated by tissue T reg cells will be important for the design of effective and specific therapies aimed at modulating T reg cells and their products in cancer and other diseases.
T reg cell memory in tissues
The generation of memory is one of the hallmarks of adaptive immunity, and it is becoming clear that T reg cells are no exception to the rule. During viral infections, the expansion of antigen-specific T reg cells is followed by a contraction phase and the formation of a memory pool 73, 74 . Upon reinfection, these memory T reg cells rapidly expand and effectively control specific antiviral responses by CD4 + and CD8 + T cells. An accelerated accumulation of memory T reg cells is observed in nonlymphoid tissues targeted by the infection; furthermore, memory T reg cells can suppress the collateral tissue damage and inflammation elicited by recall expansion of non-T reg memory CD4 + T cells. A link between T reg memory cells and tissue-resident T reg cells has also been demonstrated in the context of autoimmunity 40 . Using a TCR-neo-self-antigen double-transgenic model (transgenes encoding the DO11.10 TCR combined with transgenes specifying inducible, skin-specific expression of ovalbumin), a recent study showed that upon local induction of ovalbumin expression, ovalbumin-specific T reg cells accumulate in the skin 40 . After resolution of the inflammatory response, activated T reg cells remain in the target tissue in high frequencies and are primed to attenuate subsequent autoimmune responses when the antigen is reexpressed. These memory T reg cells can survive in the nonlymphoid tissues in the absence of overt expression of antigen and show enhanced functional activity.
In human skin, resident T reg cells comprise 5-10% of total skin T cells 75 . These T reg cells express the memory T cell marker CD45RO and are thus typically referred to as 'effector-memory T reg cells' , although their true memory nature has not been formally demonstrated. They reside preferentially in the epidermis, where Langerhans cells induce their proliferation in a manner dependent on major histocompatibility complex (MHC) class II and IL-15 (ref. 76) . It has been proposed that self peptides or the normal skin microbiome might be the source of antigens presented by Langerhans cells. Human skin-resident T reg cells also proliferate in response to pathogens 76 and during the recall response induced by injection of tuberculin purified-protein derivative (PPD) in individuals immunized with bacille Calmette-Guérin 77 .
Memory T reg cells also seem to have an important function in preventing fetal rejection in successive pregnancies 78 . Fetal antigenspecific T reg cells, generated by conversion of Foxp3 − CD4 + T cells, expand >100-fold through parturition, remain at enriched numbers after delivery and reaccumulate with accelerated kinetics during subsequent pregnancies. The precise localization of memory T reg cells in fetal-maternal nonlymphoid tissues remains unknown. Although in the case of pregnancy, the target tissue is present only transiently and memory T reg cells seem to be maintained in lymphoid organs, their specificity to fetal antigen and existing evidence of the presence of T reg cells in placenta and uterus [79] [80] [81] suggest that memory T reg cells might migrate to these tissues in recurrent pregnancies to exert their protective role.
Thus, evidence suggests that there is a close association between tissue-resident T reg cells and memory T reg cells. The generation of regulatory memory is emerging as an important factor to control the accelerated and enhanced recall responses to secondary exposure to antigens. The localization of memory T reg cells in the target nonlymphoid tissues seems to be key for their function and, in some cases, for the maintenance of the memory T reg cell pool during the remission period.
Perspectives
The study of tissue-resident T reg cells is a relatively new area of T reg cell biology. It is not surprising, then, that some key questions remain unanswered or even unaddressed. Here we highlight three questions that particularly intrigue us and are interesting realms to explore.
First, how widespread is the phenomenon? Given the distinct T reg cell compartments already found to be associated with adipose npg 1 0 1 2 VOLUME 14 NUMBER 10 OCTOBER 2013 nature immunology R e v i e w tissue, muscle, the colon and other tissues, it is theoretically possible that there is a specialized type of T reg cells dedicated to maintaining homeostasis in each tissue. Or it might be that evolution has provided dedicated T reg cell types only for those tissues particularly prone to insult (for example, the skin and muscle) or in especially close communication with the environment (such as the skin and the gut). An alternative possibility is that there are a limited number of T reg cell types and each tissue T reg compartment represents a different optimum mix of the various subsets-that is, what we are seeing are really only unique 'averages' . A broader survey of tissue T reg cells, especially in single-cell analyses, should yield critical information bearing on this question. It may also prove informative to compare T reg cell compartments from tumors and their matched normal tissues.
Second, where do tissue-resident T reg cells come from? So far, it seems clear that, except for the case of the gut and placental compartment, tissue T reg cells do not emanate from conversion of conventional Foxp3 − CD4 + T cells. It is perhaps simplest to envisage that a precursor cell, already Foxp3 + but not committed to a particular T reg cell subphenotype, is retained in a particular tissue, likely because its TCR reacts to an antigen therein and, in response to tissue-specific cues, takes on a tissue-specific subphenotype. But it is difficult to rule out the possibility that small numbers of precursors precommitted to a particular T reg cell subphenotype are generated in the thymus and monitor their corresponding peripheral tissues, either as residents or as members of the circulating T cell pool. Such a scenario is reminiscent of the recent finding that populations of tissue-resident macrophages are generated before birth and are important elements in enforcing tissue homeostasis 53 . Perhaps these macrophages need T reg cell monitors to keep them in line. Identifying the origin of tissue-resident T reg cells would be aided by generating appropriate inducible lineage-tracer mice, for example, in PPAR-γ reporters for VAT T reg cells.
Third, what is the advantage of having unique populations of tissue-resident T reg cells? It makes perfect evolutionary sense to optimize T reg compartments for both effective survival and appropriate effector activities. This is especially true for T reg cells that will reside in a given tissue long-term, either as tissue-resident sentries or in response to chronic insult. For example, adipose tissue is an environment not generally hospitable for lymphocytes: VAT T reg cells' coopting of PPAR-γ provides these cells with properties (such as expression of the lipid transporter, CD36) that promote survival in adipose tissue. Similarly, high-level expression of amphiregulin by T reg cells in regenerating tissues (for example, muscle or intestine) arms them with the capacity to favorably impact their local environment. How common it is for tissue-resident T reg cells to coopt transcriptional programs characteristic of tissue cells (like VAT T reg cells' use of PPAR-γ, the 'master-regulator' of adipocytes) and whether there might be something special about the chromatin organization or epigenetic makeup of T reg cells that favors such adaptability remains an open question.
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